Population Pharmacokinetics of Remdesivir and GS-441524 in Hospitalized COVID-19 Patients

The objective of this study was to describe the population pharmacokinetics of remdesivir and GS-441524 in hospitalized coronavirus disease 2019 (COVID-19) patients. A prospective observational pharmacokinetic study was performed in non-critically ill hospitalized COVID-19 patients with hypoxemia. F...

Descripción completa

Detalles Bibliográficos
Autores principales: Leegwater, E., Moes, D. J. A. R., Bosma, L. B. E., Ottens, T. H., van der Meer, I. M., van Nieuwkoop, C., Wilms, E. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9211420/
https://www.ncbi.nlm.nih.gov/pubmed/35647646
http://dx.doi.org/10.1128/aac.00254-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9211420/
https://www.ncbi.nlm.nih.gov/pubmed/35647646
http://dx.doi.org/10.1128/aac.00254-22

Ejemplares similares